Cranial nerve stimulation for treatment of substance addiction
First Claim
Patent Images
1. A method of treating a patient having a substance addiction, comprising:
- directly contacting an electrode to a vagus nerve of the patient, and applying an electrical signal to said electrode; and
generating afferent action potentials on said vagus nerve to alleviate a symptom of the substance addiction,wherein the substance addiction is selected from the group consisting of cocaine addiction, alcoholism, addiction to opioids, sedative, hypnotic or anxiolytic-related disorders, hallucinogen related disorders, cannabis related disorders, amphetamine related disorders, nicotine related disorders, inhalant related disorders, phencyclidine related disorders, and polysubstance abuse disorders,wherein the symptom is a withdrawal symptom selected from the group consisting of nausea, vomiting, fever, dizziness, and profuse sweating.
2 Assignments
0 Petitions
Accused Products
Abstract
A method of treating a patient with at least one substance addiction, which comprises directly stimulating a cranial nerve, such as the vagus nerve, of a patient with an electrical pulse signal defined by a plurality of parameters to provide a therapy regimen for alleviating a symptom associated with the substance addiction.
136 Citations
1 Claim
-
1. A method of treating a patient having a substance addiction, comprising:
-
directly contacting an electrode to a vagus nerve of the patient, and applying an electrical signal to said electrode; and generating afferent action potentials on said vagus nerve to alleviate a symptom of the substance addiction, wherein the substance addiction is selected from the group consisting of cocaine addiction, alcoholism, addiction to opioids, sedative, hypnotic or anxiolytic-related disorders, hallucinogen related disorders, cannabis related disorders, amphetamine related disorders, nicotine related disorders, inhalant related disorders, phencyclidine related disorders, and polysubstance abuse disorders, wherein the symptom is a withdrawal symptom selected from the group consisting of nausea, vomiting, fever, dizziness, and profuse sweating.
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeJacob Zabara
-
Original AssigneeCyberonics, Inc, Jacob Zabara
-
InventorsTerry, Reese S. Jr., Zabara, Jacob
-
Primary Examiner(s)Layno, Carl H
-
Assistant Examiner(s)Morales, Jon Eric C
-
Application NumberUS11/118,451Publication NumberTime in Patent Office3,273 DaysField of Search607/58, 607/2, 607/42US Class Current607/45CPC Class CodesA61N 1/36014 External stimulators, e.g. ...A61N 1/36053 adapted for vagal stimulati...A61N 1/36089 Addiction or withdrawal fro...
